Pacific Biosciences of California, Inc.

PACB

$15.08

+194.63% (1 year change)

Avg closing price

Price range

Market Cap

$2.82 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

Revenue

$17.1 Million

Total revenue in the last quarter.

Net Income

$-23.1 Million

Net income is all revenues minus all expenses including taxes and interest in the last quarter.

Earnings per Share

$-0.28

Earnings per share is the amount of net income that is attributed to each single share outstanding.

Dividends per Share

-

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Price-Earnings Ratio

-53.06x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

EBIT

$-23.5 Million

Earnings before interest expenses and taxes in the last quarter.

Employees

404

The number of full time employees.

Revenue & Earnings

Balance Sheet

Pacific Biosciences of California, Inc.

Pacific Biosciences of California, Inc. engages in the development, manufacture and sale of an integrated platform for genetic analysis. Its products and services include PacBio sequel system, consumables, analytical software, and single molecule real-time (SMRT) compatible products. It operates through the following geographical segments: North America, Europe, and Asia Pacific. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA.

News

Pacific Biosciences of California prices equity offering (NASDAQ:PACB)

Pacific Biosciences of California prices equity offering (NASDAQ:PACB)

Pacific Biosciences of California (NASDAQ:PACB) has priced underwritten public offering of ~7.4M shares at $14.25/share, for gross proceeds of ~$86.9M. The

Seeking Alpha Seeking Alpha, 13 days ago
Pacific Biosciences of California (NASDAQ:PACB) Stock Price Up 5.2%

Pacific Biosciences of California (NASDAQ:PACB) Stock Price Up 5.2%

Pacific Biosciences of California (NASDAQ:PACB) shares shot up 5.2% during mid-day trading on Thursday . The stock traded as high as $13.86 and last traded at $13.77. 2,846,571 shares were traded d...

The Olympia Report The Olympia Report, about 1 month ago
$20.40 Million in Sales Expected for Pacific Biosciences of California (NASDAQ:PACB) This Quarter

$20.40 Million in Sales Expected for Pacific Biosciences of California (NASDAQ:PACB) This Quarter

Analysts forecast that Pacific Biosciences of California (NASDAQ:PACB) will announce $20.40 million in sales for the current fiscal quarter, Zacks Investment Research reports. Three analysts have i...

Daily Political Daily Political, about 1 month ago